Bellevue Life Sciences enters $20M PIPE with Toonon Partners for Series A Preferred Stock

OSR Holdings, Inc.

Agreed to issue 222,222 Series A Preferred shares at $90/share to Toonon Partners for $20M total.
Proceeds to fund working capital after closing of business combination with OSR Holdings.
Series A Preferred carries 5% annual dividend, convertible into common at $9.00/share.
Company has redemption option after 1 year at 7% accrued; holders after 3 years.
PIPE closing conditioned on business combination completion and filing of Certificate of Designations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.